Ind-Swift is the biggest gainer in the BSE's 'B' group. The company is currently trading at Rs. 11.29, up by 1.88 points or 19.98% from its previous closing of Rs. 9.41 on the BSE. The scrip opened at Rs. 9.38 and has touched a high and low of Rs. 11.29 and Rs. 9.28 respectively. So far 123800 shares were traded on the counter.
Syncom Formulations (India), Bharat Immunologicals & Biologicals Corporation and Earum Pharmaceuticals are among the other gainers in the BSE's 'B' group.
Syncom Formulations (India) is currently trading at Rs. 9.74, up by 1.62 points or 19.95% from its previous closing of Rs. 8.12 on the BSE.
Bharat Immunologicals & Biologicals Corporation is currently trading at Rs. 44.85, up by 7.45 points or 19.92% from its previous closing of Rs. 37.40 on the BSE.
Earum Pharmaceuticals is currently trading at Rs. 2.96, up by 0.49 points or 19.84% from its previous closing of Rs. 2.47 on the BSE.
| Company Name | CMP |
|---|---|
| Sun Pharma Inds. | 1652.00 |
| Dr. Reddys Lab | 1235.20 |
| Cipla | 1211.30 |
| Zydus Lifesciences | 923.10 |
| Lupin | 2312.35 |
| View more.. | |
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: